MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
159 hedge funds and large institutions have $2.96B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% more funds holding
Funds holding: 112 → 159 (+47)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Holders
159
Holding in Top 10
7
Calls
$66.1M
Puts
$32.6M
Top Buyers
| 1 | +$164M | |
| 2 | +$70.6M | |
| 3 | +$65M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$33.2M |
Top Sellers
| 1 | -$63.6M | |
| 2 | -$46M | |
| 3 | -$42.3M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$19.4M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$17.5M |